Swoop, the leading provider of custom direct to consumer (DTC) and healthcare provider (HCP) audiences, today launched its portfolio of predictive AI targeting to help pharmaceutical and life sciences advertisers proactively engage audiences at critical decision points in the diagnosis and treatment journey. Building on its predictive AI adherence...
SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and biophysical modeling to redefine precision medicine for cancer, announced today it has entered into a strategic collaboration agreement with Mayo Clinic for the development of novel digital precision medicine solutions for breast cancer patients.
The...
Pan-cancer study showed MTM/mL dynamics were more predictive of therapy response than mVAF dynamics, with an observed hazard ratio nearly 2x higher
Natera, Inc., a global leader in cell-free DNA testing, announced a new study published in Molecular Oncology comparing the performance of mean tumor molecules per milliliter (MTM/mL) against mean...
The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors
ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, announced a partnership with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and...
Fauna Bio, a biotechnology company improving human health by leveraging animal genomics, announced a multi-year agreement with Eli Lilly and Company to apply Fauna's Convergence™ artificial intelligence (AI) platform to support preclinical drug discovery efforts in obesity. The two teams will collaborate to identify multiple drug targets.
Under the terms...
Body Vision Medical announces distribution agreements for Argentina, Bolivia, Paraguay, Uruguay and Mexico
Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced its exclusive distribution agreements with DeLeC Científica Uruguaya S.A. for Argentina, Bolivia, Paraguay and Uruguay and with Bio Scan S.A. for Mexico. These strategic partnerships facilitate Body Vision's aim to expand access to its cutting-edge LungVision™ real-time, intraoperative...
Absci, a generative AI drug creation company, and PrecisionLife®, a leading computational biology company driving precision medicine in complex chronic diseases, announced a collaboration to develop a joint portfolio of potential therapeutics addressing unmet medical needs. The collaboration combines Absci’s speed and strength in antibody design and optimization with...
ImmunoScape, a biotechnology company focused on the discovery and development of next-generation T cell receptor (TCR)-based therapeutics, and MiNK Therapeutics, Inc, a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell targeting therapies, announced a collaboration agreement to discover...
Dxcover Limited, a clinical-stage diagnostics company pioneering Multi-Omic Spectral Analysis for early detection of multiple cancers, announced that Founder and newly announced CEO Matthew Baker, PhD, will be presenting at Biotech Showcase 2024. Prof. Baker will be presenting data from the company’s clinical studies in early detection of solid...
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that it has been included in a recent Gartner report, entitled, Emerging Tech: Tech Innovators for Generative AI NovelDrug Discovery.
About Standigm's technology
Standigm offers three complementary platforms for drug discovery and repurposing:
Standigm ASK, an AI-aided...
